STEVEN DAVIS

Profile

First Name

: STEVEN

Middle Name

:

Last Name

: DAVIS

Related Companies

Titles

Company Name

Related People

EXECUTIVE OFFICER

MICHAEL R. CONN, PERRY COOPER, ANTHONY D-ANNIBALE, BENJAMIN D. FISCHMAN, JOEL HEBERLEIN, MARGUERITE J. HILL, CHERYL KAPLAN, MARK MCWEENY, CHRISTOPHER PAYNE, MICHAEL G. RUBIN, SUSAN STANDIFORD, MARK WEINBERG, DANIEL J. WINTERS

DIRECTOR

THERAGENE PHARMACEUTICALS, INC.

JON BERGLIN, DANIEL COURY, CHAOJIE ZHANG

EXECUTIVE OFFICER, PROMOTER

5 ARCH INCOME FUND 1, LLC

LLC 5 ARCH ASSET MANAGEMENT, GENE CLARK, TIM GANNAWAY, SHAWN MILLER

DIRECTOR

STEMBIOSYS INC.

CATHERINE BURZIK, PAUL CASTELLA, JEAN CHEEVER, XIAO-DONG CHEN, XIAO-DONG CHEN, M.D., IAN CLEMENTS, STEVEN DAVIS, M.D., JOHN W FEIK, EDWARD GRIFFEY, MARK HORSEY, MARK D HORSEY, ROBERT HUTCHENS, ROBERT S LANGER, PETER SAVAS, CHEN XIAO-DONG

DIRECTOR

LATTITUDE INTERNATIONAL, INC.

GREG GARNER, JOHN GRIMM, CHRISTOS NICOLAIDIS, YUVAL SHENKAL

DIRECTOR

PHILTER LABS INC

GREG GARNER, JOHN GRIMM, CHRISTOS NICOLAIDIS, YUVAL SHENKAL

DIRECTOR

JAMES PLANTE, GREGORY SIMON

EXECUTIVE OFFICER, DIRECTOR

THOMAS COLE, ALEX POULIN

Filings

Filing Date

Filing Type

Source URL

Industry Classifier

Detailed Industry

Revenue Range

Securities

First Sale Date

D

OTHER TECHNOLOGY

DECLINE TO DISCLOSE

Equity

2024-11-22

D

OTHER

DECLINE TO DISCLOSE

Equity

2022-06-30

D

OTHER

DECLINE TO DISCLOSE

Equity

2020-11-20

D

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity

2019-05-03

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity, Debt

2016-04-14

D

OTHER

DECLINE TO DISCLOSE

Debt

2018-03-14

D/A

BIOTECHNOLOGY

DECLINE TO DISCLOSE

Equity, Debt

2016-04-14

D

BIOTECHNOLOGY

NO REVENUES

Equity

2015-07-27

D

OTHER REAL ESTATE

DECLINE TO DISCLOSE

Equity

2014-09-01

D

BIOTECHNOLOGY

NO REVENUES

Equity

2014-02-28

D

RETAILING

DECLINE TO DISCLOSE

Equity

2011-12-28